Synergistic microglial modulation by laminarin-based platinum nanozymes for potential intracerebral hemorrhage therapy
Xiumei Guo,
No information about this author
Qionghua Zheng,
No information about this author
Wen Gao
No information about this author
et al.
Biomaterials,
Journal Year:
2025,
Volume and Issue:
319, P. 123212 - 123212
Published: Feb. 24, 2025
Language: Английский
Drug delivery strategy of hemostatic drugs for intracerebral hemorrhage
Junyan An,
No information about this author
Zhilin Liu,
No information about this author
Yihan Wang
No information about this author
et al.
Journal of Controlled Release,
Journal Year:
2025,
Volume and Issue:
379, P. 202 - 220
Published: Jan. 10, 2025
Intracerebral
hemorrhage
(ICH)
is
associated
with
high
rates
of
mortality
and
disability,
underscoring
an
urgent
need
for
effective
therapeutic
interventions.
The
clinical
prognosis
ICH
remains
limited,
primarily
due
to
the
absence
targeted,
precise
options.
Advances
in
novel
drug
delivery
platforms,
including
nanotechnology,
gel-based
systems,
exosome-mediated
therapies,
have
shown
potential
enhancing
management.
This
review
delves
into
pathophysiological
mechanisms
provides
a
thorough
analysis
existing
treatment
strategies,
emphasis
on
innovative
approaches
designed
address
critical
pathological
pathways.
We
assess
benefits
limitations
these
offering
insights
future
directions
research
highlighting
transformative
next-generation
systems
improving
patient
outcomes.
Language: Английский
Multifunctional MnO2 nanosheet based DNA tetrahedron- photosensitizer nanoplatform for gene-photodynamic modulation
Chemical Engineering Journal,
Journal Year:
2025,
Volume and Issue:
unknown, P. 159807 - 159807
Published: Jan. 1, 2025
Language: Английский
Advancements in Engineering Tetrahedral Framework Nucleic Acids for Biomedical Innovations
Qin Fan,
No information about this author
Bing-Yao Sun,
No information about this author
Jie Chao
No information about this author
et al.
Small Methods,
Journal Year:
2024,
Volume and Issue:
unknown
Published: Nov. 1, 2024
Tetrahedral
framework
nucleic
acids
(tFNAs)
are
renowned
for
their
controllable
self-assembly,
exceptional
programmability,
and
excellent
biocompatibility,
which
have
led
to
widespread
application
in
the
biomedical
field.
Beyond
these
features,
tFNAs
demonstrate
unique
chemical
biological
properties
including
high
cellular
uptake
efficiency,
structural
bio-stability,
tissue
permeability,
derived
from
distinctive
3D
structure.
To
date,
an
extensive
range
of
tFNA-based
nanostructures
intelligently
designed
developed
various
applications
such
as
drug
delivery,
gene
therapy,
biosensing,
engineering,
among
other
emerging
fields.
In
addition
role
delivery
systems,
also
possess
intrinsic
that
render
them
highly
effective
therapeutic
agents
treatment
complex
diseases,
arthritis,
neurodegenerative
disorders,
cardiovascular
diseases.
This
dual
functionality
significantly
enhances
utility
research,
presenting
valuable
opportunities
development
next-generation
medical
technologies
across
diverse
diagnostic
platforms.
Consequently,
this
review
comprehensively
introduces
latest
advancements
field,
with
a
focus
on
benefits
nanoplatforms,
inherent
capabilities
agents.
Furthermore,
current
limitations,
challenges,
future
perspectives
explored.
Language: Английский